Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Newsight Tech Angels is an Israeli investment group and angel network that serves as the founding financial and strategic backer for Newsight Imaging. The group specializes in supporting advanced CMOS image sensor technology, which has been adapted for high-precision spectral analysis in the healthcare and environmental sectors. Through its strategic investments, the group has enabled the development of the Virusight Diagnostic platform, a joint venture with Sheba Medical Center that provides rapid, non-invasive detection of pathogens such as COVID-19. Newsight Tech Angels focuses on bridging the gap between semiconductor innovation and commercial medical applications, particularly in point-of-care diagnostics. The group is comprised of seasoned technology investors who provide both capital and industry expertise to scale sensing solutions globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Newsight Tech Angels.